Shocking WHO Announcement: Mpox Still a Global Public Health Emergency in 2024!

Shocking WHO Announcement: Mpox Still a Global Public Health Emergency in 2024!

Mpox continues to escalate as a global public health emergency, according to the World Health Organization (WHO). On November 22, 2024, WHO reaffirmed this designation, which was initially declared in August after a new, more virulent strain of the virus began spreading rapidly. The outbreak originated in the Democratic Republic of Congo and has since

What Are the Benefit of Expanding Access to Weight-Losing Drugs?

Key Insights: Potential Life-Saving Impact: Expanding access to new weight-loss medications could save over 40,000 lives annually in the U.S. Obesity Crisis: 74% of Americans are overweight, and 43% are obese, contributing to severe health issues like type 2 diabetes and cardiovascular disease. Pharmaceutical Breakthrough: GLP-1 receptor agonists (e.g., Ozempic, Wegovy) and GIP/GLP-1 receptor agonists